Hyperguides

Plastic surgery / Plastic Surgery

Postoperative Pain Management in Breast Surgery: Advances that Improve Patient Outcomes

Jacob L. Hutchins, MD; Martin I. Newman, MD, FACS, FAAPS; Brandon Reynolds, MD ; Joseph M. Serletti, MD, FACS
Course overview
 
 
Author(s)/Faculty: Jacob L. Hutchins, MD; Martin I. Newman, MD, FACS, FAAPS; Brandon Reynolds, MD
; Joseph M. Serletti, MD, FACS
Type: Slides-Audio Lecture
Release Date: 11/26/2014 Expiration Date: 11/25/2015
Credit Type: CME/Participation Number of Credit(s): 1

by Joseph M. Serletti, MD, FACS; Jacob L. Hutchins, MD; Martin I. Newman, MD, FACS, FAAPS; Brandon Reynolds, MD

Support Statement:This activity is supported by an educational grant from Pacira Pharmaceuticals, Inc.

Target Audience: The intended audience for the activity is plastic surgeons and other health care professionals involved in the treatment of patients who have undergone breast reconstruction.

Learning Objectives: Upon successful completion of this educational activity, participants should be better able to:

  1. Examine current post-surgical practice patterns in regard to pain management in patients who have undergone surgical procedures on the breast.
  2. Compare the use of longer-acting local anesthetics with shorter-acting local anesthetics and opioid drugs for postoperative pain following breast surgery.
  3. Assess the benefits and risks of opioids and local analgesics to better select therapy that will meet the needs of individual patients and improve postsurgical outcomes.

Course Chair Joseph M. Serletti, MD, FACS Chief, Division of Plastic Surgery Henry Royster-William Maul Measey Professor in Plastic and Reconstructive Surgery University of Pennsylvania Health System Philadelphia, PA

Faculty Jacob L. Hutchins, MD Director of Perioperative and Interventional Pain Service Department of Anesthesiology University of Minnesota Minneapolis, MN

Martin I. Newman, MD, FACS, FAAPS Program Director and Head of Clinical Research Department of Plastic Surgery Cleveland Clinic Florida Weston, FL

Brandon Reynolds, MD Board Certified Plastic Surgeon Las Vegas, NV

This enduring material is approved for 1 year from the date of original release, November 26, 2014, to November 25, 2015.

External Reviewer Liza C. Wu, MD

Disclosures In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page and the next page.

Planning Committee and Faculty members report the following relationship(s): Joseph M. Serletti, MD No relevant financial relationships to disclose.

Jacob L. Hutchins, MD Consulting Fee: Pacira Pharmaceuticals, Inc Speakers’ Bureau: Pacira Pharmaceuticals, Inc; I-Flow Contracted Research: Pacira Pharmaceuticals, Inc

Martin I. Newman, MD Consulting Fee: Ethicon; Lifecell; MiMedex; MTF; Pacira Pharmaceuticals, Inc Speakers’ Bureau: Lifecell; Pacira Pharmaceuticals, Inc

Brandon Reynolds, MD No relevant financial relationships to disclose.

External Reviewer reports the following relationship(s): Liza C. Wu, MD No relevant financial relationships to disclose.

Unlabeled and Investigational Usage The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.